Zobrazeno 1 - 10
of 15
pro vyhledávání: '"ُSeyed Ruhollah Mousavinasab"'
Autor:
Samar Tavana, Nazafarin Hatami-Mazinani, Seyed Ruhollah Mousavinasab, Mohammad Amin Agah, Adeleh Sahebnasagh
Publikováno v:
مجله علمی دانشگاه علوم پزشکی کردستان, Vol 26, Iss 7, Pp 60-73 (2022)
Background and Aim: Community-acquired pneumonia (CAP) remains one of the leading causes of hospital admissions and a common cause of death. Population-based studies assessing the etiology and incidence of CAP are lacking in developing countries. In
Externí odkaz:
https://doaj.org/article/32cd11fa1c824bd383493456b1455ea8
Autor:
Amirreza Roostaei Firozabad, Zohreh Akhoundi Meybodi, Seyed Ruhollah Mousavinasab, Adeleh Sahebnasagh, Mohsen Gholinataj Jelodar, Iman Karimzadeh, Solomon Habtemariam, Fatemeh Saghafi
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Levamisole has shown clinical benefits in the management of COVID-19 via its immunomodulatory effect. However, the exact role of Levamisole effect in clinical status of COVID-19 patients is unknown. We aimed to evaluate the effica
Externí odkaz:
https://doaj.org/article/63f3a29e22464352a3256cb130044cba
Publikováno v:
Journal of Pharmaceutical Care, Pp 65-69 (2020)
Evaluation of stress ulcer prophylaxis guideline in the intensive care units of a Namazi Hospital, Shiraz, Iran: A Retrospective survey Afsaneh Vazin1,Seyed Ruhollah Mousavinasab1*, Golnar Sabetian2* 1 Department of Clinical Pharmacy, Faculty
Externí odkaz:
https://doaj.org/article/ce03b3cb720e45b2ab1aae971253f6cc
Autor:
Guitti Pourdowlat, Seyed Ruhollah Mousavinasab, Behrooz Farzanegan, Alireza Kashefizadeh, Zohreh Akhoundi Meybodi, Maedeh Jafarzadeh, Shadi Baniasadi
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-3 (2021)
Abstract Objectives Basic and clinical studies have shown that magnesium sulphate ameliorates lung injury and controls asthma attacks by anti-inflammatory and bronchodilatory effects. Both intravenous and inhaled magnesium sulphate have a clinical im
Externí odkaz:
https://doaj.org/article/e4eedf0ac23344dc92bd917af731dbf9
Autor:
Mohsen Zabihi, Fatemeh Askarian, Seyedhossein Hekmatimoghaddam, Mohammadreza Rashidi Nooshabadi, Mohammad Sajjad Zabihi, Seyed Ruhollah Mousavinasab
Publikováno v:
Advances in Pharmacological and Pharmaceutical Sciences, Vol 2021 (2021)
Background. Myopathy is one of the side effects of lipid-lowering drugs, especially statins and particularly when combined with a fibrate. To diagnose myopathy and determine its severity, the plasma levels of three enzymes, creatine kinase (CK), aldo
Externí odkaz:
https://doaj.org/article/2afd4be836794e07a628387f3359a9aa
Publikováno v:
Journal of Pharmaceutical Care, Vol 7, Iss 4 (2020)
Background: IV acetaminophen has become the most commonly chosen analgesic medication in critical care settings. Overall, the cost of the drug is higher than oral and rectal acetaminophen. As a result, numerous studies have been performed to evaluate
Externí odkaz:
https://doaj.org/article/75ee6cfa31214de2bdb220edacfe6944
Autor:
Zohreh Akhondi-Meybodi, Golbarg Mehrpoor, Sina Owlia, Mehrdad Aghaei, Seyed Ruhollah Mousavinasab, Mohammad Bagher Owlia, Zahra Mirfeizi
Publikováno v:
Rheumatology Research. 5:145-151
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus which has led to a pandemic. There is no approved treatment for coronavirus disease 2019 (COVID-19). Over time, physicians came to understand that in some severe patients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39124eee2cf425cec5f2b52581cc261b
https://doi.org/10.22631/rr.2020.69997.1104
https://doi.org/10.22631/rr.2020.69997.1104
Autor:
Guitti Pourdowlat, Fatemeh Saghafi, Abolfazl Mozafari, Adeleh Sahebnasagh, Atefeh Abedini, Mohsen Nabi Meybodi, Ali Salehi Nezamabadi, Seyed Ruhollah Mousavinasab, Arda Kiani, Hanieh Raji, Nadia Soltani, Mehdi Gholmzadeh Baeis, Esmaeil Eidani, Abdolrahim Sadeghi Yakhdani, Fatemeh Movaseghi, Solomon Habtemariam, Zohreh Akhoundi Meybodi, Mohsen Gholinataj Jelodar
Publikováno v:
Phytotherapy research : PTRREFERENCES. 36(2)
Colchicine has shown clinical benefits in the management of COVID-19 via its anti-inflammatory effect. However, the exact role of colchicine in COVID-19 patients is unknown. The current clinical trial was performed on 202 patients with moderate to se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6351aebbe901e40ac31d929a1dc6ffb9
https://pubmed.ncbi.nlm.nih.gov/35107188
https://pubmed.ncbi.nlm.nih.gov/35107188
Publikováno v:
Rheumatology Research. 5:87-89
Among the most common chronic conditions needing chronic drug therapy are chronic rheumatic diseases, diabetes mellitus,hypertension, depression, psychosis, inflammatory bowel diseases, multiple sclerosis, coronary vascular disease, dyslipidemiaand a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f454ec27e8c91348dbb02f0f701f8ca
https://doi.org/10.22631/rr.2020.69997.1096
https://doi.org/10.22631/rr.2020.69997.1096
Autor:
Iman Karimzadeh, Fatemeh Saghafi, Adeleh Sahebnasagh, Solomon Habtemariam, Seyed Ruhollah Mousavinasab, Amirreza Roostaei Firozabad, Zohreh Akhoundi Meybodi, Mohsen Gholinataj Jelodar
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
Background Levamisole has shown clinical benefits in the management of COVID-19 via its immunomodulatory effect. However, the exact role of Levamisole effect in clinical status of COVID-19 patients is unknown. We aimed to evaluate the efficacy of Lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17db338900ad2595caf7c8a192448a3f
http://europepmc.org/articles/PMC7988635
http://europepmc.org/articles/PMC7988635